Status:
ACTIVE_NOT_RECRUITING
Spasmodic Dysphonia Interviews
Lead Sponsor:
Manchester University NHS Foundation Trust
Conditions:
Spasmodic Dysphonia
Quality of Life
Eligibility:
All Genders
18+ years
Brief Summary
Previous research has shown that patients with voice disorders often have a lower quality of life and struggle with employment. Spasmodic Dysphonia (SD) is a voice disorder that causes abrupt and unco...
Eligibility Criteria
Inclusion
- Adults diagnosed with Spasmodic Dysphonia who have received at least one botulinum toxin injection.
Exclusion
- Below 18 years of age; additional laryngeal condition(s) severely affecting voice.
Key Trial Info
Start Date :
August 20 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 30 2025
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT06561334
Start Date
August 20 2024
End Date
September 30 2025
Last Update
September 25 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Manchester University NHS Foundation Trust
Manchester, United Kingdom